Polymyalgia rheumatica and giant cell arteritis are related conditions almost exclusively occurring in older people. Polymyalgia rheumatica is considered to be the rheumatic disease that is subject to the widest variations of clinical practice, partially due to the considerable uncertainty related to diagnosis and outcomes. Giant cell arteritis, an inflammatory form of vasculitis, may present with a broad spectrum of clinical manifestations and can be complicated by acute ischaemic events, the most serious of which is permanent blindness. Early recognition and adequate treatment of the condition is thus necessary to prevent loss of independency of patients and to maintain their quality of life.
Table of Contents
- Part 1 Epidemiology, pathogenesis, and clinical presentation
- Part 2 Diagnostic work-up
- Part 3 Guidelines for treatment
- Part 4 Outcomes, prognosis, socioeconomic implications, primary care, and patient perspectives